Chinook Therapeutics Price on December 30, 2022

KDNYDelisted Stock  USD 39.25  0.20  0.51%   
If you're considering investing in Chinook Stock, it is important to understand the factors that can impact its price. As of today, the current price of Chinook Therapeutics stands at 39.25, as last reported on the 29th of November, with the highest price reaching 39.37 and the lowest price hitting 38.95 during the day. We have found thirty technical indicators for Chinook Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Chinook Therapeutics' Downside Deviation of 2.61, mean deviation of 2.8, and Risk Adjusted Performance of 0.1168 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Chinook Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
KDNY
Based on monthly moving average Chinook Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chinook Therapeutics by adding Chinook Therapeutics to a well-diversified portfolio.

Related Headline

Structure Therapeutics Headline on 2nd of February 2023

Filed transaction by Structure Therapeutics In officer. Unconventional Insider trading

Chinook Therapeutics Valuation on December 30, 2022

It is possible to determine the worth of Chinook Therapeutics on a given historical date. On December 30, 2022 Chinook was worth 25.76 at the beginning of the trading date compared to the closed value of 26.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Chinook Therapeutics stock. Still, in general, we apply an absolute valuation method to find Chinook Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chinook Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Chinook Therapeutics' related companies.
 Open High Low Close Volume
  25.42    26.34    25.03    25.90    439,928  
12/30/2022
  25.76    26.22    25.70    26.20    307,004  
  26.20    26.25    24.87    25.44    481,636  
Backtest Chinook Therapeutics  |  Chinook Therapeutics History  |  Chinook Therapeutics Valuation   PreviousNext  
Open Value
25.76
26.2
Closing Value
25.76
Upside

Chinook Therapeutics Trading Date Momentum on December 30, 2022

On January 03 2023 Chinook Therapeutics was traded for  25.44  at the closing time. The top price for the day was 26.25  and the lowest listed price was  24.87 . The trading volume for the day was 481.6 K. The trading history from January 3, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.90% . The overall trading delta against the current closing price is 3.47% .

Chinook Therapeutics Fundamentals Correlations and Trends

By evaluating Chinook Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Chinook Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Chinook financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Chinook Therapeutics Stock history

Chinook Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Chinook is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Chinook Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Chinook Therapeutics stock prices may prove useful in developing a viable investing in Chinook Therapeutics
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington. Chinook Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 138 people.

Chinook Therapeutics Stock Technical Analysis

Chinook Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Chinook Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Chinook Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Chinook Therapeutics Period Price Range

Low
November 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Chinook Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Chinook Therapeutics November 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Chinook Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chinook Therapeutics shares will generate the highest return on investment. By undertsting and applying Chinook Therapeutics stock market strength indicators, traders can identify Chinook Therapeutics entry and exit signals to maximize returns

Chinook Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Chinook Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Chinook Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Chinook to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Chinook Stock

If you are still planning to invest in Chinook Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chinook Therapeutics' history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Share Portfolio
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation